Related Experiment Videos

Transcriptomic Stratification Reveals an FRS2-Associated, Proliferation-Independent Phenotype in MDM2-High Sarcomas

Takao Sakai1, Hisaki Aiba1, Makoto Yamaguchi1

  • 1Department of Orthopaedic Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan.

Summary

MDM2-amplified sarcomas may have underestimated metastatic risk. Fibroblast growth factor receptor substrate 2 (FRS2) correlates with MDM2 but not proliferation, indicating potential for aggressive behavior assessment.